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Abstract The shuttlewalk test (SWT) is a validated, incrementalwalking test for chronic obstructive pulmonary dis-
ease, but not for idiopathic pulmonary fibrosis (IPF).The measurement of maximal oxygen consumption (VO2 max) is
consideredtobethegold standardmeasurementof functionalcapacity.This studyexamines therelationshipbetween IPF
patients’performance on the SWTand VO2 max.Twenty patientswere recruited for the study, which consisted of two
separateexperiments.Firstly, therelationshipbetween SWTperformanceonaconventionalcorridor SWT,withthaton
a programmable treadmill SWT designed to reproduce the corridor SWTwas examined (n=10). In the second experi-
ment, therelationshipbetweenperformance onthetreadmillequivalent SWTand VO2maxmeasurementswas studied
(n=10).Therewas a significantcorrelationbetweendistancewalkedonthe corridor SWT, and thatwalkedonthe tread-
mill equivalent SWTwithout VO2maxmeasurements (367m vs.410m) (r=0.91,P=0.0003).Therewas a significantcorre-
lation between distance walked on the treadmill equivalent SWT (277m), and the directly determined VO2 max
(14.87ml/kg/min) (r=0.74,P=0.01).Duringbothexperiments, a significantcorrelationwas also observedbetweenbaseline
PaO2 and SWT performance, and between DLCO and SWT performance.The shuttle walk test is a simple objective
measure of functional capacity in IPF patients, which should facilitate the evaluation of new therapeutic compounds for
IPF.r2003 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2003.1501, available online athttp://www.sciencedirect.com
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Unlikemany simple exercise tests (1,2), the shuttle walk-
ing test (SWT) is a standardized, incremental walking
test, stressing the individual to a symptom limited max-
imal performance (3).The fact that this test is externally
paced overcomes the limitations that have made other
self-paced walking tests (1,2) lose favour as objective
measures of functional capacity.The SWT canbe carried
out in any clinical unit without the need for special facil-
ities and takes relatively little time to complete. The
SWThas previouslybeendemonstrated to be areprodu-
cible measure of functional capacity in patients with
chronic obstructive pulmonary disease (COPD) (4,5),
cystic ¢brosis (6), heart failure (7), and in patients with
pacemakers (8); but such data is not available in patients
with idiopathic pulmonary ¢brosis (IPF).With the adventReceived 28 May 2002, accepted in revised form 21September 2002
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for IPF, a standardized tool for estimating functional ca-
pacity is vital.Themeasurement ofmaximal oxygen con-
sumption (VO2 max) by analysis of expired air during a
maximal exercise laboratory test, is considered to be
the gold standard measurement of functional capacity
(4), howevermeasuringVO2max is resource demanding.
Therefore, this study was undertaken in order to pro-
vide a standardized endpoint which can be easily applied
in therapeutic trials.
This study examines the relationship between IPF pa-
tients’ performance on the SWTand VO2 max, employ-
ing two di¡erent approaches. In the ¢rst experimentwe
measured the distancewalkedduring a conventional cor-
ridor SWT, and examined whether it was equivalent to
the distance walked during a programmable treadmill
test, designed to reproduce the corridor SWT.In the sec-
ondexperimentwemademeasurements of theVO2max
during the treadmill equivalent SWT.These two experi-
ments allowed us to examine the relationship between
VO2 max and performance during the SWT in IPF pa-
tients.
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Patient selection criteria
Out-patients with usual interstitial pneumonia (UIP)-pat-
tern IPF were studied. All subjects gave informed con-
sent, and the local hospital ethics committee approved
the study.The diagnosis of UIP was based on either high-
resolution computed tomography (HRCT) or an open
lung biopsy (OLB). All patients had been treated with
corticosteroids and various chemotherapeutic regimes
before and after referral. Exclusion criteria were: (a) the
presence of known histories of collagen vascular disease,
allergic alveolitis, or exposure to organic dusts; (b) pa-
tients with a tissue diagnosis of non-speci¢c interstitial
pneumonia (NSIP)/¢brosis, desquamative interstitial
pneumonia (DIP), respiratory bronchiolitis associated
with interstitial lungdisease (RBILD), or bronchiolitis ob-
literans organizing pneumonia (BOOP); (c) patients with
a predominantly ground-glass attenuation onHRCTscan
(9,10); and (d) patients who demonstrated an objective
response to corticosteroids alone.
HRCTscanning
All patients underwent HRCT of the chest. All HRCT
scans were obtained immediately after referral, using a
Picker PQ scanner (Picker International, Cleveland,
OH). The HRCT scans consisted of 1.5-mm-thick slices
acquired at 10-mm increments through the thorax, re-
constructed with a high spatial frequency algorithm.
Scans were performed at end-inspiration with the pa-
tients in the supine position; no intravenous contrast
was given.HRCT criteria for diagnosing UIP were as fol-
lows (9,11): (a) a reticular pattern of intralobular intersti-
tial thickening demonstrating a peripheral, subpleural,
and basal predominance with irregular pleuroparenchy-
mal interfaces; (b) may show areas of honeycombing
and traction bronchiectasis; (c) ground-glass opaci¢ca-
tion may be present but the reticular pattern predomi-
nates; (d) consolidation and nodulesmust be absent.
Surgical lung biopsies
Surgical lung biopsies were completed either through a
thoracotomy incision or by video-assisted thorascopic
surgery. The site of the biopsy was directed by HRCT.
The diagnosis of UIP was based on the following histo-
pathologic criteria (12): (a) a variegate picture of intersti-
tial ¢brosis, in£ammation, and normal tissue; (b)
tendency for ¢brosis to subpleural and peripheral distri-
bution; (c) the absence of the uniform ¢brotic changes
characteristic of NSIP and of features indicating other
causes (e.g. asbestos bodies, granulomata).Lung physiology
Spirometry (Vmax 22; Sensormedics Yorba Linda, CA),
and DLCO (P.K. Morgan, Rainham, England) were mea-
sured. All lung function measurements were performed
in the same laboratory. DLCO values were corrected to
haemoglobin. Alveolar volume (VA) was measured by a
single-breath helium dilutionmethod, and di¡using capa-
city per unit volume (KCO) was calculated by dividing
DLCO by VA. Values were expressed as absolute values
and, where appropriate, as percentages of the predicted
values calculated according to sex, weight, and age.The
de¢nitions and methods for performing lung volumes
and di¡using capacity followed the recommendation of
the European Coal and Steel Community.(13,14) All lung
functionmeasurements used in this study were obtained
immediately before SWT.
Study design
Aprospective, randomized studyof 20 out-patientswith
IPF was performed, which consisted of two separate ex-
periments. In the ¢rst, we examined the relationship be-
tween shuttle test performance on a conventional
corridor SWTand a programmable treadmill SWT, de-
signed to reproduce the corridor SWT (n=10). In the sec-
ond experiment, using a di¡erent cohort of IPF patients,
we examined theVO2 max during the treadmill equiva-
lent SWT (n=10).Table1 shows the demographics of the
two groups. Subjects had no impacting interventions,
prior to, or during the study. For each experiment, pa-
tientswere required tomake twovisits at the same time
of day to the pulmonary laboratory at intervals of ap-
proximately 1 week. The ¢rst visit of each experiment
was for the purpose of familiarization, and the patients
performed one practice corridor SWTand one practice
treadmill equivalent SWT according to the established
protocol (3). The two experiments were performed in
two di¡erent patient groups to control for the training
of equipment familiarization.
Corridor shuttlewalk test
Brie£y, as previously described,(3) the corridor SWT re-
quires patients towalk at increasing speeds up and down
a10mcourseusingmarker cones that are placed 0.5m in
from each end, avoiding the need for any abrupt change
in direction.The speed of walking, increasing everymin-
ute, is controlled by audio signals played from a tape cas-
sette.The end of the test is determined by either (a) the
patient, when he or she is too breathless tomaintain the
required speed or (b) the operator, if the patient fails to
complete a shuttle in the time allowed (that is, is more
than 0.5m away from the cone when the bleep sounds)
or (c) attainment of 85% of the predictedmaximal heart
rate.
TABLE 1. Characteristics ofthepatients according to pa-
tientgroup
Evaluatedparameter Experiment1 Experiment 2
No. of subjects 10 10
Age, year 59.1712.1 58.5712.7
Male/ female 6/4 5/5
Steroids (mg) 17.573.5 12.271.2
Pack years 23.7719.8 27717.9
FEV1, l 1.970.7 1.670.5
FEV1, %pred 71723 58713
FVC, l 2.470.9 2.070.7
FVC, %pred 74723 55712
DLCO, ml/min/mmHg 3.170.4 3.871.4
DLCO, %pred 41712 47714
KCO, mmol/kPa/min 0.970.4 1.271.4
KCO, %pred 69728 95721
Baseline pH 7.470.01 7.470.01
Baseline PaO2, kPa 8.771.6 9.172.2
O2 desaturation, % 974.6 776.2
Maximumheart rate, bpm 124725 130724
*Values aremeans7SD.
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FIG. 1. Correlation between the performance distance on the
corridor shuttle walk test and the performance distance on the
treadmill equivalent shuttlewalk test (n=10).
684 RESPIRATORYMEDICINETreadmill equivalent shuttlewalk test
During the treadmill equivalent SWT, a programmable
powerjog machine was employed (Cardiokinetics Ltd,
Salford,UK).This used a speed of 30m/min for the ¢rst
minute, with the speed increasing by 10m/min for each
subsequent minute, designed to reproduce the corridor
SWT.There was no incline on the treadmill throughout
the test.During both the corridor and treadmill equiva-
lent SWT, heart rate and oxygen saturations were re-
corded using a portable pulse oximeter, and VO2 max
was recorded during the treadmill equivalent SWT by
analysis of expired air using amass-£ow sensor to detect
air£ow with a VMAX 229 system (Sensormedics, Yorba
Linda, CA). A noseclip was used throughout the entire
treadmill equivalent SWT period.
During the ¢rst experiment, the two exercise tests
were organized in a randomized, single blinded design,
i.e. the corridor SWTor the treadmill equivalent SWT
without VO2 max measurements, both performed on
the same day, with a rest period of 45min between the
tests. During the second experiment, subjects per-
formed only the treadmill equivalent SWT test, with
VO2 maxmeasurements.
Statistical analysis
Datawere shown to be normally distributed as analysed
using a validated statistical software package for perso-
nal computers (Graph Pad Prism Inc., San Diego).To as-
sess the strength of the relationship between two
variables, the co-e⁄cient of correlation (Pearson’s) de-notedby ‘‘r’’was calculated.Values arepresented asmean
(CI) unless otherwise stated, and a 5% level of signi¢-
cancewas adopted throughout.
RESULTS
Relationship between performance on the
corridor SWTand treadmill equivalent SWT
without VO2maxmeasurement
Therewas a signi¢cant correlationbetween the distance
walked on the corridor SWT, mean (CI) 367m (252.4^
481.6), and the treadmill equivalent SWT 409.9m
(232.7^587.1), (r=0.91, P=0.0003) (Fig.1). A signi¢cant cor-
relation was also observed between baseline PaO2,
8.7kPa (7.4^9.9) and corridor SWT distance (r=0.78,
P=0.01), andbetweenbaseline PaO2 and treadmill equiva-
lent SWT distance (r=0.73, P=0.02).There was no di¡er-
ence between the O2 desaturation from baseline after
the corridor SWT, 9% (1^18), and the treadmill equiva-
lent SWT 9% (3^15), (P=0.85). There was a signi¢cant
correlation between DLCO, 3.1ml/min/mmHg (2.1^4.2)
and corridor SWT distance (r=0.89, P=0.003), and be-
tween DLCO and treadmill equivalent SWT distance
(r=0.89,P=0.003); however therewas no relationship be-
tween KCO, 0.9mmol/kPa/min (0.6^1.3) and corridor
SWT distance (r=0.66, P=0.07), and between KCO and
treadmill equivalent SWT distance (r=0.59, P=0.12).
Furthermore, there was no relationship between FEV1,
1.9 l/min (1.3^2.4) and corridor SWT distance (r=0.34,
P=0.41), and between FEV1 and treadmill equivalent
SWTdistance (r=0.43,P=0.29).Therewas norelationship
between FVC, 2.4 l/min (1.6^3.2) and corridor SWT dis-
tance (r=0.004, P=0.99), and between FVC and tread-
mill equivalent SWT distance (r=0.009, P=0.98). There
was no relationship between the maximum heart rate
recorded after the corridor SWT,118 bpm (94^143) and
corridor SWT distance (r=0.35, P=0.49), and no relation-
ship between the maximum heart rate recorded after
SHUTTLEWALKEXERCISE ANDPULMONARYDISEASE 685the treadmill equivalent SWT, 124 bpm (106^142) and
treadmill equivalent SWT distance (r=0.44, P=0.20).
Relationship between treadmill equivalent
SWTand VO2max
The relationship between the distance walked on the
treadmill equivalent SWT, 277.3m (167.8^386.8), and the
directly determined VO2 max 14.87ml/kg/min (12.04^
17.70) was strong (r=0.74, P=0.01) (Fig. 2). A signi¢cant
correlation was also observed between baseline PaO2,
9.1kPa (7.6^10.7) and treadmill equivalent SWT distance
(r=0.67, P=0.03).The O2 desaturation frombaseline, after
the treadmill equivalent SWTwas 7% (1^12).Therewas a
signi¢cant correlation between DLCO, 3.8ml/min/mmHg
(2.7^4.8) and treadmill equivalent SWTdistance (r=0.68,
P=0.03), however there was no relationship between
KCO,1.2mmol/kPa/min (1.0^1.4) and treadmill equivalent
SWT distance (r=0.15, P=0.68). Furthermore, there was
no relationship between FEV1, 1.6 l/min (1.3^2.0) and
treadmill equivalent SWT distance (r=0.44, P=0.20).
There was no relationship between FVC, 2.0 l/min (1.4^
2.5) and treadmill equivalent SWT distance (r=0.54,
P=0.10). There was no relationship between the maxi-
mum heart rate recorded after the treadmill equivalent
SWT, 130 bpm (113^147) and treadmill equivalent SWT
distance (r=0.41, P=0.24).
DISCUSSION
Themain ¢nding from this study is that the SWT is a re-
liablemeasure of functional capacity in patients with IPF.
Our data in IPF patients demonstrate a strong relation-
ship between the distance walked during a conventional
corridor SWT, and thatwalkedduring a treadmill equiva-
lent SWT, designed to reproduce the corridor SWT.We
further demonstrate, for the ¢rst time in IPF patients, a
signi¢cant correlation between treadmill equivalent0 100 200 300 400 500
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FIG. 2. Correlation between the performance distance on
the treadmill equivalent shuttle walk test and the VO2 max
(n=10).SWT performance and VO2 max. This should facilitate
the evaluation of novel therapeutic compounds.
The corridor SWT has previously been demonstrated
tobe a reproduciblemeasure of functional capacity inpa-
tients with chronic obstructive pulmonary disease (3). A
patient’s maximal oxygen consumption plays a decisive
role in his or her physical performance (15) and is re-
garded as the best physiological measurement of endur-
ance performance. However, the pathophysiology of
COPD and IPF are di¡erent. In IPF, the fall in PaO2 with
exercise is due to a combination of ventilation^perfusion
mismatch, shunt, and alveolar^ capillary di¡usion limita-
tion (16^18); whereas in COPD, the major contributing
factor to hypoxemia with exercise is inadequate ventila-
tory response causing the PaCO2 to rise and the PaO2 to
fall (16).Therefore, although the SWT is accepted as a va-
lidated tool for estimating exercise capacity in COPD,(3)
it could not, until now, be assumed to be a validmeasure
in IPF patients.
All the patients in our study reported that breathless-
ness was the major factor in stopping the test. Cardio-
vascular factors appeared to be relatively unimportant
in limiting the exercise tolerance, as the maximal heart
rates were lower than predicted values anticipated for
the patients’ age, suggesting a ventilatory limit to exer-
cise. It has recently been demonstrated that the SWT is
a reproduciblemethod for evaluating the impactof short-
ness of breath on functional capacity in ambulantpatients
with advanced cancer (19). Furthermore, the reversal of
deconditioning as a contribution to improvingbreathless-
ness in COPD is an important part of pulmonary rehabi-
litation.(20) The evidence for the general bene¢ts of
exercise is becoming clear frommany branches of medi-
cine(21,22) and should not be neglected in IPF patients.
The assessment of exercise capacity in patients with
IPF potentially provides an objective index of their dis-
ability and reveals functional abnormalities not obvious
in lung function measurements made at rest. It would
seem reasonable to suggest that patients’ static lung
function test results should relate well to their exercise
ability, but this is not the case.We found a poor correla-
tion between patients’ FEV1and FVCvalues and exercise
capacity. This is consistent with recent studies showing
that hypoxemia, and not respiratory mechanics, predo-
minantly limit maximal incremental exercise in patients
with IPF (23,24).
We found a good correlation in IPF patients between
baseline levels of hypoxia and performance distance on
the SWT, suggesting that supplemental oxygenmay result
in improvements in exercise tolerance anddyspnoea in this
patient population.This hypothesis is supported by recent
studies showing that supplemental oxygen improves max-
imal exercise performance in patientswith interstitial lung
disease (23,24), and also that thegreatestbene¢twith sup-
plemental oxygen was in subjects with more severe dis-
ease, as evidencedby a reduced DLCO (23,24).
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between DLCO and performance distance on the SWT.
This is important for two reasons.Firstly, in a study eval-
uating lung function in IPF andreferral for lung transplan-
tation, Mogulkoc et al. (25) showed using receiver
operating characteristic (ROC) curve analysis thatDLCO
was themost important predictor of survival in IPF. Sec-
ondly,Kingetal. (26) recentlydemonstratedusing amore
complex clinical, radiological and physiological (CRP)
score, that VO2max was amajor variable in determining
a CRP score utilized to predict survival in IPF.Therefore
the signi¢cant relationship between exercise and DLCO
in this study suggests that SWTmay complement simple
methods for predicting survival.
Simple exercise tests can be employed to reveal the
true extentof disability and assess patients’ability toper-
formday-to-day activities.However, other exercise tests
of disability, such as the 6 and 12min walk tests have no
standardizedpace or incremental facility (3), and the lack
of uniform instructions for operators or patients results
in a variety of test procedures being adopted.The SWT
has the advantage in that it is standardized, incremental,
and externally paced, diminishing the e¡ect of the oper-
ator’s in£uence. Unlike the 6 or 12min walking tests
where e¡ort may be maximal from the start, the SWT
stresses the patient progressively to a symptom-limited
maximum.This gradual increase in exercise intensity in-
creases the safety of the test.Moreover, an advantage of
the shuttlewalking test is that it has a better correlation
with peak oxygen uptake than the 6min walking
test (27).
Maximal oxygen consumption has previously been
measured during a corridor SWT in COPD patients
using a portable oxygen consumption meter supported
by abackpack,with themouthpiece supportedby a head
harness (4). However, with this method there was a sig-
ni¢cant underestimation in ventilation by the portable
meter, and patients consistently reported that the oxy-
gen consumption equipment had inhibited their perfor-
mance (4). Therefore, the most precise method of
measuring VO2 max is by analysis of expired air during a
maximal exercise laboratory test.
In summary, the present study substantiates the pro-
posal that the SWT is a simple incremental maximal ex-
ercise test of disability that provides an objective
measure of IPF patients’ cardiorespiratory capacity. This
provides a toolwhichmaycomplementexistingphysiolo-
gic and radiological measures of disease progression as
novel therapeutic agents for IPF are being developed.
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